GO analysis of stage-salient genes in the order of decreasing significance (i.e, increasing p–value). by Sangeetha Muthamilselvan (8966006)

“…<p>GO analysis of stage-salient genes in the order of decreasing significance (i.e, increasing p–value).</p>…”

Percentage reduction in mortality resulting from total removal of traffic emissions (for COPD and IHD, age group is 50–55 years). by Shahram Heydari (11785878)

Subjects: “…respiratory diseases increases…”

Occurrence of species that increased and decreased across surveys. by Paul H. Zedler (2905520)

Increasing gaps and decreasing returns attenuate spending effects. by William Minozzi (8564712)

The application of GTDE efficiently increased the D-gal induced decline in the expression levels of BDNE. by Hui-Chuan Kuo (12368492)

Subjects:

The variation trend of |BD| value with age: With the increase of age, the |BD| values decreased significantly (p<0.01). by Yunmeng Da (707943)

Autophagy significantly increases RGCs loss. by Hongmei Qian (538647)

Autophagy significantly increases RGCs loss. by Hongmei Qian (538647)

Increased connectivity in the red lines and decreased connectivity in the blue lines. by Tomoki Kaneko (9113490)

“…There is no significant increase/decrease in each seed.</p>…”

Factors associated with increased PDFF (≥30% from baseline). by Natthaya Chuaypen (6726911)

Hyperplasia of the suboccipital muscles significantly increased intracranial pressure. by Chan Li (433717)

Subjects:

Number of patients with a significant increase or significant decrease between the baseline measurement (SCr-BL) and the creatinine measurement at emergency department presentation (SCr-ED). by M. S. A. Niemantsverdriet (11886431)

Transgenic FAR expression significantly decreases fly survival and increases bacterial load 24-hours post-injection. by Sophia C. Parks (11624976)

Modelling the significance of prevalence reduction from pre- to post-intervention surveys. by Kareen Atekem (14290058)

“…<p>Modelling the significance of prevalence reduction from pre- to post-intervention surveys.…”

Trends in the days of sulfamethoxazole-trimethoprim therapy per 100 patients, by month, during Phases 1 to 4. by Naoya Itoh (6029276)

Subjects:

Trends in in-hospital mortality by month during the pre-intervention period (Phase 1) and interventional period (Phases 2–4). by Naoya Itoh (6029276)

Subjects:

Trends in the days of cefalexin therapy per 100 patients, by month, during Phases 1 to 4. by Naoya Itoh (6029276)

Subjects:

Trends in the days of quinolone therapy per 100 patients, by month, during Phases 1 to 4. by Naoya Itoh (6029276)

Subjects:

Trends in the length of hospital stay by month during the pre-intervention period (Phase 1) and interventional period (Phases 2–4). by Naoya Itoh (6029276)

Subjects:

Trends in the days of macrolides therapy per 100 patients, by month, during Phases 1 to 4. by Naoya Itoh (6029276)

Subjects: